Patient-reported financial barriers to adherence to treatment in neurology.
| Autor: | Moura LM; Department of Neurology., Schwamm EL; Department of Neurology., Moura Junior V; Department of Neurology., Seitz MP; Department of Neurology., Hoch DB; Department of Neurology., Hsu J; Mongan Institute for Health Policy, Massachusetts General Hospital; Department of Medicine and Department of Health Care Policy, Harvard Medical School, Boston, MA, USA., Schwamm LH; Department of Neurology. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2016 Nov 17; Vol. 8, pp. 685-694. Date of Electronic Publication: 2016 Nov 17 (Print Publication: 2016). |
| DOI: | 10.2147/CEOR.S119971 |
| Abstrakt: | Objective: Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders. Patients and Methods: Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as "nonadherence". Results: The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, p <0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, p =0.01), living alone (13.9% vs 8.9% cohabitating, p <0.01), and preferred a language other than English (15.3% vs 9.4%, p =0.02). Conclusion: Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics. Competing Interests: The authors report no conflicts of interest in this work. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|